Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Adamis Pharmaceuticals Corp (NASDAQ:ADMP)

8.76
Delayed Data
As of May 27
 +0.255 / +3.00%
Today’s Change
3.05
Today|||52-Week Range
10.98
+62.22%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization0.000.00296.1K990.3K
 
 
 
 
Operating ExpensesGross Income0.000.00-296.1K-990.3K
 
 
 
General Expenses4.8M3.2M4.1M12.9M
 
 
 
 
 
Research And Development1.9M1.2M1.0M4.8M
 
 
 
 
 
Total Operating Expenses4.8M3.2M4.4M13.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-4.8M-3.2M-4.4M-13.9M
 
 
 
 
 
Extraordinary Credit----4.9M278.4K
 
 
 
Extraordinary Charge---1.5M----
 
 
Interest Expense On Debt35.4K2.3M8.6M0.00
 
 
 
 
Other Expenses5.3K0.000.000.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-4.8M-7.1M-8.2M-13.6M
 
 
 
 
 
Discontinued Operations-70.0K-130.0K0.000.00
 
 
 
Net Income-4.9M-7.2M-8.2M-13.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS5.3M5.9M7.3M13.3M
 
 
 
 
 
Shares To Calculate EPS Diluted5.3M5.9M7.5M13.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.02-$1.19-$1.22-$1.03
 
 
 
 
 
EPS Diluted-$0.85-$1.19-$1.22-$1.03